TACHOSIL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug TACHOSIL contains a combination of these active pharmaceutical ingredients (APIs):

1	Human fibrinogen UNII N94833051K - FIBRINOGEN HUMAN
	Human fibrinogen (coagulation factor I), in the presence of thrombin, activated coagulation factor XIII (F XIIIa) and calcium ions is converted into a stable and elastic three-dimensional fibrin haemostatic clot. The administration of human fibrinogen concentrate provides an increase in plasma fibrinogen level and can temporarily correct the coagulation defect of patients with fibrinogen deficiency.
	Read more about Human fibrinogen
2	Thrombin UNII 6K15ABL77G - HUMAN THROMBIN
	Read more about Thrombin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BC30	Combinations	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BC Local hemostatics
Discover more medicines within B02BC30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	501104501170319
EE	Ravimiamet	1207875, 1212220, 1212231, 1212242, 1687204
ES	Centro de información online de medicamentos de la AEMPS	04277001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	019293, 019435, 019440
FR	Base de données publique des médicaments	61695844
GB	Medicines & Healthcare Products Regulatory Agency	147173, 147177, 90677
HK	Department of Health Drug Office	61690, 61691, 63148
IL	מִשְׂרַד הַבְּרִיאוּת	6689, 7483
IT	Agenzia del Farmaco	036557015, 036557027, 036557039, 036557041, 036557054
JP	医薬品医療機器総合機構	6349802X1020, 6349802X2027, 6349802X3023
LT	Valstybinė vaistų kontrolės tarnyba	1030977, 1030978, 1030979, 1030980, 1076190
PL	Rejestru Produktów Leczniczych	100027378
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68190001, W68190002, W68190003
SG	Health Sciences Authority	14441P
TR	İlaç ve Tıbbi Cihaz Kurumu	8683324499235
US	FDA, National Drug Code	0338-8701, 0338-8702
ZA	Health Products Regulatory Authority	45/8.1/0937